Larson Financial Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-228
Closed -$23.2K 3695
2025
Q4
$23.2K Buy
228
+134
+143% +$10.8K ﹤0.01% 1629
2025
Q3
$5.14K Sell
94
-262
-74% -$13.1K ﹤0.01% 2344
2025
Q2
$18.9K Sell
356
-254
-42% -$12.9K ﹤0.01% 1516
2025
Q1
$26.4K Buy
610
+589
+2,805% +$29.8K ﹤0.01% 1252
2024
Q4
$1.18K Hold
21
﹤0.01% 1994
2024
Q3
$1.43K Buy
21
+6
+40% +$339 ﹤0.01% 1913
2024
Q2
$634 Sell
15
-21
-58% -$1.16K ﹤0.01% 1792
2024
Q1
$2.49K Buy
36
+35
+3,500% +$2.21K ﹤0.01% 1331
2023
Q4
$74 Sell
1
-23
-96% -$1.51K ﹤0.01% 1729
2023
Q3
$1.64K Sell
24
-192
-89% -$16.3K ﹤0.01% 1396
2023
Q2
$20.3K Buy
+216
New +$16.9K ﹤0.01% 736

Other funds holding EXAS

Larson Financial Group's EXAS Position: Q1 2026 in Review

Larson Financial Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 228 shares — an estimated $23.2K sold.

Larson Financial Group first reported a position in EXAS in Q2 2023 and held it in 11 quarters. The position peaked at $26.4K in Q1 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Larson Financial Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Larson Financial Group sold 228 Exact Sciences shares in Q1 2026, an estimated $23.2K.
  • Larson Financial Group first reported a position in Exact Sciences in Q2 2023 and held it in 11 quarters.
  • Larson Financial Group's Exact Sciences position peaked at $26.4K in Q1 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.